USP12 and breast cancer: To validate the results of our screens, we used Crispr/Cas9 technology to knockout (KO) the USP12, USP46, WDR20, and WDR48 genes either individually or in combination in at least two different mouse fibroblast and human breast cancer MDA-MB-231 cell clones, respectively.